Summary
Wheezing in infants and toddlers is a common symptom, and these patients are difficult to approach — both diagnostically and therapeutically. Congenital conditions causing wheezing disorders should not be missed and — not all wheezy bronchitis is or will become asthma. Results from longitudinal studies indicate that the term «asthma» includes different phenotypes: so-called transient early wheezing, non atopic wheezing and atopic wheezing (asthma).Transient early wheezing is generally accepted to define recurrent wheezing in non-atopic babies or toddlers and tends to disappear by the age of 3. The primary risk factor is reduced pulmonary function since birth. The most common cause fornon-atopic wheezing is viral infection, most frequently caused by respiratory syncytial virus. Infection with respiratory syncytial virus is a risk factor for ongoing wheeze during childhood but resolves in most children by the age of 13.Asthma can start at any age and is determined by a more chronic condition, provoked by a number of triggers in addition to viruses, frequently associated with a family history of atopy, early allergic sensitization and concomitant atopic dermatitis. Only asthma seems to be a progressive disease; and there is evidence from long-term studies that if anti-inflammatory interventions are started late, it might be too late to alter the natural course of the disease with its decline in pulmonary function. On the other hand, there is no evidence that small children with non-atopic wheezy bronchitis would benefit from long-term therapy with anti-inflammatory treatment; in this group a therapeutic trial with bronchodilators is sufficient. The diagnostic and therapeutic challenges of diagnosing asthma in this age group are considerable and require a comprehensive approach.
Zusammenfassung
Die pfeifende Atmung («Wheezing) beim Säugling und Kleinkind ist ein häufiges Symptom das zur diagnostischen und therapeutischen Herausforderung werden kann. Differentialdiagnostische Überlegungen spielen in dieser Altersgruppe eine besondere Rolle und nicht jedes Wheezing ist oder wird zu Asthma bronchiale. Die Ergebnisse von Langzeitstudien zeigen, dass es verschiedene «Asthmaphänotypen» gibt, das «transient early wheezing», das «non atopic wheezing» und «das atopic wheezing (asthma)».Transient early wheezing findet sich vor allem Säuglingen und Kleinkindern ohne Hinweis für eine Atopie und verschwindet üblicherweise im Alter von ca. 3 Jahren. Ursache hierfür sind eine schon bei Geburt verminderte Lungenfunktion im Sinne kleiner Atemwege. Der häufigste Grund für dasnon atopic wheezing sind Virusinfektionen, vor allem mit dem Respiratory Syncytial Virus, welche einen Risikofaktor für wheezing während der Kindheit bedeuten. Die Symptomatik verliert sich aber um das 13. Lebensjahr.Asthma kann in jedem Alter beginnen und ist charakterisiert durch einen mehr chronischen Verlauf, Auslöser sind neben viralen Infektionen eine Reihe anderer Ursachen: eine positive Familienanamnese bezüglich Atopie, eine frühe allergische Sensibilisierung und eine begleitende atopische Dermatitis. Wie aus den Longitudinalstudien hervorgeht ist nur Asthma im engeren Sinne eine progressive Erkrankung. Daten aus Longitudinalstudien zeigen, dass bei Asthma bronchiale der Verlust an Lungenfunktion bereits in früher Kindheit beginnt und therapeutische Interventionen rechtzeitig begonnen werden sollten, um einen irreversiblen Verlust an Lungenfunktion zu verhindern. Andererseits ist im Falle einer gelegentlichen «Wheezy bronchitis» ein symptomorientierter Therapieversuch mit Bronchodilatoren ausreichend. Im frühen Kindesalter ist oft eine zuwartende Haltung unumgänglich und die Diagnose Asthma kann häufig erst retrospektiv gestellt werden.
Similar content being viewed by others
Literatur
Pedersen S, Silverman M, Martinez F (1998) The back-ground to early intervention. Eur Respir J 12 [Suppl 27]: 1s-2s
Wahn U, von Mutius E (2001) Childhood risk factors for atopy and the importance of early intervention. J Allergy Clin Immunol 107: 567–574
Martinez FD (2002) Development of wheezing disorders and asthma in preschool children. Pediatrics 109: 362–367
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan W, et al (1995) Asthma and wheezing in the firs six years of life. N Engl J Med 332: 133–138
Martinez FD (2001) Links between pediatric and adult asthma. J Allergy Clin Immunol 107: S449–455
Horak E, Lanigan A, Roberts M, Welsh L, Olinsky A, Robertson CF (2003) Longitudinal study of childhood wheezy bronchitis and asthma — outcome at age 42. BMJ 326: 422–423
Strachan DP, Griffiths JM, Johnston IDA, Anderson HR (1996) Ventilatory function in British adults after asthma or wheezing illness at ages 0–35. Am J Respir Crit Care Med 154: 1629–1635
Jenkins MA, Hopper JL, Bowes G, Carlin J, Flander LB, Giles GG (1994) Factors in childhood as predictors of asthma in adult life. BMJ 30: 90–93
Sears MR, Justina MG, Willan AR, Wiecek EM, Taylor RD, Flannery EM, et al (2003) A longitudinal, population based, cohort study of childhood asthma followed to adulthood. N Engl J Med 348: 1414–1422
Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ and Martinez FD (2003) Tucson Children’s Respiratory Study: 1980 to present. J Allergy Clin Immunol 111: 661–675
Duncan KJ, Silverman M (1999) Are we too ready to diagnose asthma in children. Thorax 54: 625–628
Hogg C, Bush A (1997) Childhood asthma — all that wheezes is not inflammation. Clin Exp Allergy 27: 991–994
Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD (2000) A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 162: 1403–1406
Kjellman N, Croner S (1984) Cord blood IgE determination for allergy prediction: a follow up to seven years of age in 1651 children. Allergy 53: 571–578
Nickel R, Kulig M, Forster J, Bergmann R, Bauer CP, Lau S, et al (1997) Sensitization to hen’s egg at the age of 12 months is predictive for allergic sensitization to common indoor and outdoor allergens at the age of three years. J Allergy Clin Immunol 99: 613–617
Lodrup CKC, Halvorsen R, Ahlstedt S, Carlsen KH (1995) Eosinophil cationic protein and tidal flow volume loops in children 0–2 years of age. Eur Respir J 8: 1148–1154
Koller DY, Wojnarowski C, Herkner KR, Weinlander G, Raderer M, Eichler I, et al (1997) High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 99: 752–756
Wilson NM, James A, Uasuf C, Payne DN, Hablas H, Agrofioti C, et al (2001) Asthma severity and inflammation markers in children. Pediatr Allergy Immunol 12: 125–132
Rhodes HL, Thomas P, Sporik R, Holgate ST, Cogswell JJ (2002) A birth cohort sudy of subjects at risk of atopy. Twenty-two-year follow up of wheeze and atopic status. Am J Respir Crit Care Med 165: 176–180
Kotaniemi-Syrjänen A, Reijonen TM, Romppanen J, Korhonen K, Savolainen K, Korppi M (2003) Allergen specific immunglobulin E antibodies in wheezing infants; the risk for asthma in later childhood. Pediatrics 111: e255-e261
Godfrey S, Bar-Yishay E, Avital A, Springer C (2003) What is the role of tests of lung function in the management of infants with lung disease? Pediatr Pulmonol 36: 1–9
Weiner DJ, Allen JL, Panitch HB (2003) Infant pulmonary function testing. Curr Opin Pediatr 15: 316–322
Young S, Arnott J, O’Keeffe PT, Le Souef PN, Landau LI (2000) The association between early life lung function and wheezing during the first 2 years of life. Eur Respir J 15: 151–157
Stick SM, Burton PR, Gurrin L, Sly PD, Le Souef PN (1996) Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in new-born infants. Lancet 348: 1060–1064
Zacharasiewicz A, Zidek T, Haidinger G, Waldhor T, Suess G, Vutuc C (1999) Indoor factors and their association to respiratory symptoms suggestive of asthma in Austrian children aged 6–9 years. Wien Klin Wochenschr 111: 882–886
Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al (1999) Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354: 541–545
Cohen L, Castro M (2003) The role of viral respiratory infections in the pathogenesis and exacerbation of asthma. Semin Respir Infect 18: 3–8
Martinez FD (2003) Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis 22: S76-S82
Wellevier RC (2003) Respiratory syncytial virus and other respiratory viruses. Pediatr Infect Dis 22: S6-S12
Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B (2000) Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161: 1501–1507
Phelan PD, Robertson CF, Olinsky A (2002) The Melbourne Asthma Study: 1964–1999. J Allergy Clin Immunol 109: 189–194
Zeiger RS, Dawson C, Weiss S (1999) Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol 103: 376–387
Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, et al (2002) Risk factors for airway remodeling in asthma manifested by a low post bronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 165: 1467–1468
Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR (2002) Outcome in adulthood of asymptomatic airway hyperresponsiveness in childhood: a longitudinal population study. Pediatr Pulmonol 34: 164–171
Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST (2003) Airway remodeling in asthma: new insights. J Allergy Clin Immunol 111: 215–225
Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al (1991) Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 325: 388–392
Selroos O, Pietinalho A, Löfroos AB, Riska H (1995) Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 108: 1228–1234
Agertoft L, Pedersen S (1994) Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88: 373–381
Vonk JM, Jongepier H, Panhuysen CIM, Schouten JP, Bleecker ER, Postma DS (2003) Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 58: 322–327
Allen DB (2002) Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 109: 373–380
Bazzy-Asaad A (2001) Safety of inhaled corticosteroids in children with asthma. Curr Opin Pediatr 13: 523–527
Allen DB (2002) Safety of inhaled corticosteroids in children. Pediatr Pulmonol 33: 208–220
Becker AB, Chan-Yeung M (2002) Primary prevention of asthma. Curr Opin Pulm Med 8: 16–24
Riedler J, Braun-Fahrländer C, Eder W, Schreuer M, Waser M, Maisch S, et al (2001) Exposure to farming in early life and development of asthma and allergy: a cross sectional survey. Lancet 358: 1129–1133
Johnson CC, Alford SH (2002) Do animals on the farm and in the home reduce the risk of pediatric atopy? Curr Opin Allergy Clin Immunol 2: 133–139
Braun-Fahrländer C, Riedler J, Herz U, Eder W, Waser M, Grize L, et al (2002) Environmental exposure to endotoxin and ist relation to asthma in school-age children. N Engl J Med 347: 869–877
von Mutius E (2000) Presentation of new GINA guidelines for pediatrics. Clin Experimental Allergy 30: S6–10
Frischer Th, Eber E, Eichler I, Horak E, Riedler J, Götz M et al (1999) Konsensus-Empfehlungen zur medikamentösen Behandlung des Asthma bronchiale im Kindes- und Jugendalter. Wien Klin Wochenschr 111: 900–902
Eber E, Frischer T, Götz M, Horak E, Kurz H, Riedler J, et al (2003) Konsensus-Empfehlungen zur medikamentösen Behandlung des Asthma bronchiale im Kindes- und Jugendalter, 1. Addendum. Wien Klin Wochenschr 115: 604–606
Rabe KF, Vermeire PA, Soriano JB, Maier WC (1999) Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) Study. Eur Respir J 16: 802–807
Kuehni CE, Frey U (2002) Age related differences in perceived asthma control in childhood: guidelines and reality. Eur Respir J 20: 880–889
Haby MM, Powell CVE, Oberklaid F, Waters EB, Robertson CF (2002) Asthma in children: gaps between current management and best practice. J Paediatr Child Health 38: 284–289
Warner JO, Naspitz CK, Cropp GJA (1998) Third international pediatric consensus statement on the managenment of childhood asthma. Pediatr Pulmonol 25: 1–17
Gibson NA, Ferguson AE, Aitchinson TC, Paton JY (1995) Compliance with medication in preschool children. Thorax 50: 1274–1279
Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C (1996) Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 98: 1051–1057
Kamps AW, van Ewijk B, Roorda RJ, Brand PL (2000) Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol 29: 39–42
Kurz H, Riedler J (1999) Inahaltion devices for the treatment of asthma — how much do paediatricians know about their correct use. Wien Klin Wochenschr 111: 443–445
Child F, Davies S, Clayton S, Fryer AA, Lenney W (2002) Inhaler devices for asthma: do we follow the guidelines? Arch Dis Child 86: 176–179
Goetz M (1998) Childhood asthma is a wordwide concern. Wien Klin Wochenschr 110: 657–659
Martinez FD (2003) Toward asthma prevention — does all that really matters happen before we learn to read? N Engl J Med 349: 1473–1475
Wahn U, von Mutius E (2001) Childhood risk factors for atopy and the importance of early intervention. J Allergy Clin Immunol 107: 567–574
Tang MLK (2002) Is prevention of childhood asthma possible? Allergens, infections and animals. MJA 177: S75–77
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Horak, E. Pfeifende Atmung («Wheezing») beim Säugling und Kleinkind: Aktuelle Standpunkte. Wien Klin Wochenschr 116, 15–20 (2004). https://doi.org/10.1007/BF03040418
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03040418